Total and measles-containing vaccines declined markedly in all children but recovered in those aged 0 to 23 months<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
TUESDAY, April 20, 2021 (HealthDay News) — During the pandemic, there has been a decrease in total and measles-containing vaccines in all children, according to a study published online April 15 in Pediatrics<\/em>.<\/p>\n Bradley K. Ackerson, M.D., from Kaiser Permanente Southern California in Pasadena, and colleagues assessed vaccine uptake and vaccination coverage for all recommended vaccines and for measles-containing vaccines at milestone ages in a cohort of children aged 0 to 18 years during January to August 2020 and compared the uptake and coverage rates to those in the same period in 2019. Differences were assessed in prepandemic (January to March), stay-at-home (April to May), and reopening (June to August) periods in 2020 versus 2019.<\/p>\n The researchers found that compared with 2019, during the pandemic period in 2020, total and measles-containing vaccines declined markedly in all children; they recovered in children aged 0 to 23 months. Measles- containing vaccine uptake recovered after an initial decline among children aged 2 to 18 years, but the total vaccine uptake remained lower. During the pandemic period, there was a rapid decline in vaccination coverage (recommended and measles-containing vaccines), which remained reduced among most milestone age cohorts aged 24 months and younger; in older children, recommended vaccination coverage decreased during the reopening period in 2020 versus 2019.<\/p>\n “While the severe decrease in measles vaccine uptake among children improved, measles vaccine uptake remained substantially reduced, so the population of unvaccinated children is continuing to grow,” Ackerson said in a statement. <\/p>\n Several authors disclosed financial ties to the pharmaceutical industry.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n